As of January 22, 2025, Immunome (IMNM) has a market cap of $0.64 billion USD. According to our data, Immunome is ranked No.5808 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.64 B |
-3.86%
|
Dec 31, 2024 | $0.66 B |
-0.75%
|
Dec 29, 2023 | $0.67 B |
384.16%
|
Dec 30, 2022 | $0.14 B |
-82.95%
|
Dec 31, 2021 | $0.81 B |
33.88%
|
Dec 31, 2020 | $0.60 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Adaptive Biotechnologies
ADPT
|
$1.18 B |
0.000 M
|
USA
|
Vir Biotechnology
VIR
|
$1.45 B |
0.000 M
|
USA
|
Twist Bioscience
TWST
|
$3.12 B |
0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Fate Therapeutics
FATE
|
$0.15 B |
0.000 M
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Atara Biotherapeutics
ATRA
|
$39.68 M |
0.000 M
|
USA
|
Precision BioSciences
DTIL
|
$38.13 M |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
Cellectis
CLLS
|
$0.16 B |
4.659 M
|
France
|
Market Cap | = | IMNM Stock Price | * | IMNM Shares Outstanding |
= | $10.21 | * | 62.42 M | |
= | $0.64 B |